bat
sarslik
coronaviru
slcov
genom
organ
almost
ident
sarscov
nterminu
spike
protein
interact
host
receptor
major
target
neutral
antibodi
cov
two
virus
sequenc
ident
although
report
studi
overal
immunogen
sl
knowledg
precis
locat
immunodomin
determin
sl
still
lack
studi
use
seri
truncat
express
sl
fragment
sl
specif
mous
sera
identifi
two
immunogen
determin
sl
importantli
one
two
region
seem
locat
region
share
known
immunogen
determin
sar
find
potenti
use
futur
monitor
slcov
infect
bat
spillov
anim
develop
effect
vaccin
cover
broad
protect
new
group
coronavirus
sinc
first
descript
sarslik
coronaviru
slcov
lau
k
et
al
li
w
et
al
success
report
detect
group
new
coronavirus
bat
around
world
lau
k
et
al
ren
w
et
al
tang
x
c
et
al
yuan
j
et
al
pathogen
studi
use
synthes
slcov
show
could
caus
diseas
mice
acquir
small
fragment
sarscov
becker
et
al
work
highlight
potenti
slcov
spillov
nonbat
mammal
includ
human
caus
diseas
sarscov
spike
protein
sar
respons
receptor
bind
also
major
target
neutral
antibodi
base
signific
sequenc
differ
slcov
spike
protein
sl
sar
surpris
find
sera
slcov
posit
fail
neutral
sarscov
previou
studi
found
slcov
infect
bat
sera
could
recogn
hivpseudoviru
carri
sl
protein
similar
pseudoviru
carri
mutant
sl
protein
receptor
bind
region
replac
sar
protein
zhou
p
et
al
studi
postul
major
immunodomin
neutral
epitop
may
lie
region
sl
protein
use
five
truncat
express
protein
panel
sl
specif
mous
polyclon
monoclon
antibodi
identifi
two
immunogen
determin
one
locat
differ
region
identifi
sar
first
report
identifi
immunogen
determin
sl
data
present
use
futur
develop
diagnost
vaccin
slcov
b
fig
schemat
diagram
construct
purifi
protein
gener
report
fulllength
slcov
five
truncat
version
number
shown
indic
region
aa
residu
posit
fragment
b
sdspage
profil
purifi
protein
use
studi
fulllength
express
mbp
tag
kd
five
truncat
express
kd
tag
six
gene
fragment
cover
ntermin
region
sl
gene
shown
fig
obtain
pcr
use
plasmid
contain
fulllength
gene
restrict
enzym
site
incorpor
pcr
primer
pair
ecor
forward
primer
sal
revers
primer
facilit
clone
primer
sequenc
avail
upon
request
result
pcr
fragment
purifi
restrict
digest
ligat
prokaryot
express
vector
novagen
truncat
protein
vector
new
england
biolab
inc
fulllength
plasmid
sequenc
make
sure
gene
fragment
free
mutat
clone
frame
vector
encod
protein
tag
sequenc
recombin
plasmid
transform
escherichia
coli
strain
novagen
cultur
c
od
reach
protein
express
induc
h
mmoll
iptg
c
cell
harvest
resuspend
phosphatebuff
salin
pb
lyse
sonic
cycl
freezethaw
result
lysat
centrifug
min
c
clarifi
supernat
collect
appli
either
hisbind
column
novagen
truncat
fragment
amylos
resin
new
england
biolab
inc
fulllength
protein
accord
manufactur
protocol
puriti
recombin
protein
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
mous
sera
prepar
dna
immun
use
plasmid
express
slcov
gene
describ
previous
zhou
p
et
al
monoclon
antibodi
slcov
made
use
publish
standard
procedur
evan
g
et
al
briefli
balbc
mice
immun
purifi
hiv
pseudotyp
viru
produc
previou
work
zhou
p
et
al
spleen
cell
immun
mice
harvest
fuse
myeloma
cell
cell
cultur
supernat
hybridoma
contain
well
screen
elisa
use
hiv
pseudoviru
purifi
protein
coat
antigen
posit
clone
expand
inocul
intraperiton
syngen
mice
use
protocol
approv
anim
ethic
committe
wuhan
institut
virolog
ascit
fluid
tap
titer
monoclon
antibodi
determin
elisa
avoid
cross
reaction
monoclon
antibodi
tag
protein
western
blot
monoclon
antibodi
preabsorb
use
control
e
coli
lysat
contain
encod
protein
elisa
assay
perform
standard
condit
briefli
microtit
plate
coat
purifi
recombin
protein
ngwell
moll
carbon
buffer
ph
night
c
plate
wash
block
bsa
tween
incub
either
mous
sera
monoclon
antibodi
h
c
bound
antibodi
detect
use
horseradish
peroxidaseconjug
goat
antimous
igg
lingfei
tech
wuhan
china
dilut
color
develop
conduct
use
tetramethylbenzidin
tmb
absorb
nm
determin
reaction
stop
moll
h
wash
carri
five
time
use
tween
minwash
antibodi
dilut
use
bsa
tween
appropri
neg
control
includ
everi
step
protein
separ
sdspage
gel
follow
coomassi
blue
stain
use
standard
procedur
wilson
c
western
blot
analysi
separ
protein
transfer
polyvinyldifluorid
pvdf
membran
millipor
bedford
membran
block
skim
milk
tween
c
three
wash
membran
incub
overnight
c
mous
sera
monoclon
antibodi
bound
antibodi
detect
c
alkalin
phosphataseconjug
affinipur
goat
antimous
igg
proteintech
group
inc
wuhan
china
develop
use
tmb
membran
peroxidas
substrat
system
develop
membran
wash
air
dri
amino
acid
sequenc
protein
obtain
ncbi
genebank
access
sequenc
align
done
use
clustal
w
thompson
et
al
protein
structur
model
use
cphmodel
lund
et
al
pymol
delano
scientif
six
recombin
protein
includ
fulllength
five
truncat
fragment
success
express
e
coli
solubl
greatli
facilit
affin
purif
base
fuse
protein
tag
purif
puriti
analyz
sdspage
follow
coomassi
blue
stain
puriti
achiev
recombin
protein
fig
five
purifi
fragment
test
elisa
sera
four
mice
immun
plasmid
dna
encod
fulllength
fig
summar
result
immun
respons
four
immun
mice
sera
react
one
anim
react
none
react
pseudotyp
viru
ren
w
et
al
use
immun
mous
product
monoclon
antibodi
sl
success
product
antibodi
confirm
elisa
recombin
fulllength
protein
demonstr
mab
react
protein
hiv
pseudoviru
backbon
protein
data
shown
shown
western
blot
analysi
four
mab
react
protein
fig
tag
protein
four
truncat
fragment
data
shown
provid
evid
aa
immunogen
determin
howev
due
lack
suscept
cell
line
sarslik
cov
unabl
test
neutral
abil
four
mab
although
mani
studi
character
immunodomin
determin
sarscov
spike
protein
sar
hua
r
et
al
serv
import
target
vaccin
design
report
date
character
immunogen
determin
bat
slcov
spike
protein
sl
slcov
first
identifi
lau
k
et
al
li
w
et
al
may
potenti
spillov
human
minim
chang
spike
protein
lau
k
et
al
predict
confirm
recent
studi
recombin
slcov
contain
small
fragment
sarscov
gene
abl
infect
caus
diseas
mice
highlight
potenti
pathogen
human
becker
b
fig
comparison
aa
region
sl
correspond
region
sar
sarscov
aa
align
aa
sequenc
two
region
underlin
region
indic
receptor
bind
motif
rbm
aa
residu
number
provid
beneath
sequenc
align
respect
key
residu
aa
sar
highlight
asterisk
b
structur
model
receptor
bind
motif
rbm
white
correspond
region
black
region
present
absent
highlight
yellow
et
al
view
defin
immunogen
determin
sl
necessari
detect
slcov
bat
futur
vaccin
design
absenc
live
slcov
embark
studi
determin
immunodomin
determin
sl
use
mous
sera
monoclon
antibodi
rais
pseudoviru
express
full
length
sl
protein
seri
recombin
truncat
sl
express
studi
abl
show
elisa
western
blot
repres
two
immunogen
determin
mice
region
cover
aa
immunogen
two
sinc
recogn
polyclon
mous
sera
also
four
monoclon
antibodi
worth
mention
may
also
contain
conform
immunogen
determin
yet
identifi
bacteria
protein
studi
possibl
use
recombin
fulllength
protein
select
antigen
result
loss
valuabl
monoclon
screen
immunogen
determin
need
perform
protein
express
eukaryot
cell
previou
report
know
aa
sar
major
immunodomin
determin
sl
share
high
sequenc
ident
region
view
surpris
sl
also
demonstr
immunogen
mous
howev
receptor
bind
domain
rbd
sl
low
sequenc
ident
sar
especi
critic
receptor
bind
motif
rbm
region
fig
rbd
region
sar
known
major
target
neutral
antibodi
correspond
region
sl
also
show
high
level
immunogen
report
previous
zhou
p
et
al
howev
subtl
differ
observ
studi
although
residu
rbm
region
report
hotspot
neutral
antibodi
product
sar
zhu
z
et
al
correspond
region
underlin
fig
sl
fail
react
four
monoclon
antibodi
react
one
four
mous
sera
model
rbm
region
fig
two
protein
evid
two
structur
almost
ident
except
minor
differ
interestingli
sever
predict
hotspot
antibodi
target
differ
sarscov
strain
especi
cover
residu
zhu
z
et
al
highli
conserv
sl
sequenc
predict
structur
region
seem
nonimmunogen
mice
studi
could
impli
subtl
import
differ
locat
immunodomin
determin
two
protein
howev
said
current
studi
base
immun
studi
mice
rather
infect
studi
investig
requir
fulli
assess
potenti
immunogen
differ
differ
bat
slcov
protein
nevertheless
worth
note
antibodi
gener
studi
use
tool
mani
aspect
exampl
combin
specif
mab
cross
reactiv
n
proteinspecif
antibodi
design
test
could
simultan
detect
sarsrel
coronavirus
well
determin
potenti
recombin
event
gene
especi
benefici
long
term
monitor
slcov
bat
activ
pursu
mani
group
around
world
lau
k
et
al
summari
work
repres
first
attempt
determin
immunogen
determin
sl
comparison
sar
knowledg
reagent
gener
current
studi
facilit
ongo
slcov
surveil
research
includ
develop
better
diagnost
broad
spectrum
vaccin
new
group
coronavirus
